News list for " biosciences"
Nasdaq-listed Solana treasury company Artelo Biosciences announced the issuance of 640,924 common shares to the public at a price of $4.40 per share, raising a total of approximately $3 million. Artelo Biosciences is a clinical pharmaceutical company that has previously announced the official launch of a Solana-based digital asset treasury strategy and will invest part of its capital in the purchase of SOL tokens. As of now, it holds 45,883 SOL.
纳斯达克上市的Solana财库公司Artelo Biosciences宣布以每股4.40美元的价格向公众发行640,924股普通股，募集总计约300万美元资金，Artelo Biosciences是一家临床制药公司，此前已宣布正式启动基于Solana的数字资产财库战略并将部分资本投入购买SOL代币，截至目前持有45883枚SOL。
The board of directors of Nasdaq-listed Anixa Biosciences has approved the purchase of bitcoin as a reserve asset. The company also reaffirmed its ongoing share buyback program. CEO Amit Kumar said the decision on bitcoin is another approach to prudent financial management that can achieve higher shareholder value. It is reported that Anixa Biosciences is a biotechnology company focused on the treatment and prevention of cancer.
纳斯达克上市公司Anixa Biosciences董事会已批准购买比特币作为储备资产，该公司还重申了其正在进行的股票回购计划，该公司首席执行官Amit Kumar表示，关于比特币的决定是审慎财务管理的另一种方法，可以实现更高的股东价值。据悉，Anixa Biosciences是一家专注于治疗和预防癌症的生物技术公司。
